Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
about
Optical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathyBlood pressure control for diabetic retinopathyAnti-vascular endothelial growth factor for diabetic macular oedemaAntiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedemaOptical coherence tomography (OCT) for detection of macular oedema in patients with diabetic retinopathyDiabetic macular edema: it is more than just VEGFNew Diagnostic and Therapeutic Approaches for Preventing the Progression of Diabetic RetinopathyUpdates on the Clinical Trials in Diabetic Macular EdemaEpidemiology of diabetic retinopathy, diabetic macular edema and related vision lossINTRAVITREAL CORTICOSTEROIDS IN DIABETIC MACULAR EDEMA: PHARMACOKINETIC CONSIDERATIONSThe Vitreomacular Interface in Diabetic RetinopathyThe clinical utility of aflibercept for diabetic macular edemaPerspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedemaThe role of aflibercept in the management of diabetic macular edemaSystematic review and mixed treatment comparison of intravitreal aflibercept with other therapies for diabetic macular edema (DME)Clinical development of new treatments for diabetic macular oedemaEndothelial progenitor cells in diabetic retinopathyThe therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacyNew approaches for the treatment of diabetic macular oedema: recommendations by an expert panelNovel pharmacotherapies in diabetic retinopathyA review of therapies for diabetic macular oedema and rationale for combination therapyAlternative pathways in the development of diabetic retinopathy: the renin-angiotensin and kallikrein-kinin systemsNovel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?Diabetic Macular Edema Pathophysiology: Vasogenic versus InflammatoryUpdate on corticosteroids for diabetic macular edemaEvidence-based review of diabetic macular edema management: Consensus statement on Indian treatment guidelinesMoving Past Anti-VEGF: Novel Therapies for Treating Diabetic RetinopathyCurrent perspectives on ranibizumabRecent developments in laser treatment of diabetic retinopathyLong-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edemaSustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdownDiabetic macular oedema: evidence-based treatment recommendations for Asian countries.Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy.Fenofibrate and Diabetic Retinopathy.Diabetic macular edema: New promising therapies.EFFECT OF AN INTRAVITREAL DEXAMETHASONE IMPLANT ON DIABETIC MACULAR EDEMA AFTER CATARACT SURGERY.CLINICAL EVIDENCE OF THE MULTIFACTORIAL NATURE OF DIABETIC MACULAR EDEMA.Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy.Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial.Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results.
P2860
Q24186424-4BCCB60C-46F0-4D8F-9B78-941667E24DD9Q24186434-0D53F476-A1C8-4BE6-B815-3D762F0A8A3AQ24193083-DC18DEFF-DCBD-487C-A8BE-78390E849C7DQ24202071-792AD109-B10C-41C3-9F17-DE21A5440EF5Q24235325-A0468177-FB6A-43F6-AEBF-5FE281016356Q26745914-B744D49B-3DB4-4BF0-BB17-D7F4EB042456Q26765468-676B7C8D-43B7-4409-9758-E4E3DA127F0CQ26767100-9990F72D-1120-438C-90CE-036945D9D163Q26775552-969C627D-098E-4355-89C8-ED7E9759B7DDQ26782198-36F80ECC-4AC4-44CE-AB09-3CE8C07BFCF4Q26783404-FA01F5D7-5665-4428-B8CD-FC91802C0020Q26783575-FB0BB1DB-2BE7-46E3-A037-E0EDC9143FD0Q26786012-6570399D-0E37-484E-8330-463755098EF3Q26798348-C9424054-23D8-4D61-853C-4B493BDE4F27Q26823985-BAA24DB9-2D2D-48A6-8711-32A3ADA679F2Q26825365-7B5DBDCA-8D45-4859-B273-1DF3AF3AF8C8Q26827206-6E38F580-B1CF-4154-A4BF-D0E9BA26534CQ26849299-3AAE961B-DA0F-47A2-A70B-A0216D4FAB8DQ26853239-43171B66-7B15-4476-B5B7-DB080CE5E087Q27002622-B010E23A-5F94-4322-B0D6-CBB37E670C93Q27008325-05D3DF56-8CDD-4B4C-9858-59CD35D87E07Q27025635-06077FD8-715D-4BCE-836C-A9C0C9D20C54Q28066675-967C6569-6FC3-41A5-ADB8-6B20777988DAQ28070894-1FE85BCE-EED8-4724-92CB-FA15DB447338Q28074846-548A7187-E730-4ADA-9F7F-487921D74A50Q28075473-73527448-B6D2-4F66-AF5F-EBED59094AA5Q28078199-1CDE7EF8-4601-4A49-90A8-B056B1E34C21Q28082383-85F1F69D-D02D-4E13-B05F-65D6922334D5Q28084139-0F1E3CE2-48E0-4632-8839-444A9E25EB61Q28292764-5787EAFB-A7EE-43F2-9F69-73C0EF9CE6F3Q28817495-52FCA427-3D32-4411-B167-0E2EB426A817Q30101045-45AB9E7D-E522-4575-9A92-C33D50286C64Q30244247-32B4FD75-64BF-41CC-A583-F24B6EFCFFA5Q30248492-0547F697-F546-402B-AA57-CAD716DCEB8FQ30415630-0C3F9515-1DBA-4B9F-9C44-3D0321F8E66AQ30490903-C7369299-428F-4FA1-9CA9-DF61F1BE17D4Q30491050-7B59C530-FC98-4320-87EE-FF1A2EE14037Q30681823-C193FDF9-6F03-4505-9F0C-9E45ED6E6A3FQ31049802-E0B616F4-9881-470A-B4A5-A967C36506AEQ31100308-3B97F0FE-F356-4C89-9ECF-6250C11B20F1
P2860
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Randomized trial evaluating ra ...... ser for diabetic macular edema
@ast
Randomized trial evaluating ra ...... ser for diabetic macular edema
@en
Randomized trial evaluating ra ...... er for diabetic macular edema.
@nl
type
label
Randomized trial evaluating ra ...... ser for diabetic macular edema
@ast
Randomized trial evaluating ra ...... ser for diabetic macular edema
@en
Randomized trial evaluating ra ...... er for diabetic macular edema.
@nl
prefLabel
Randomized trial evaluating ra ...... ser for diabetic macular edema
@ast
Randomized trial evaluating ra ...... ser for diabetic macular edema
@en
Randomized trial evaluating ra ...... er for diabetic macular edema.
@nl
P2093
P2860
P1433
P1476
Randomized trial evaluating ra ...... ser for diabetic macular edema
@en
P2093
Adam R Glassman
Allison R Edwards
Cynthia R Stockdale
Diabetic Retinopathy Clinical Research Network
Frederick L Ferris
Ingrid U Scott
Jennifer K Sun
Kellee M Miller
Lloyd Paul Aiello
Michael J Elman
P2860
P304
1064-1077.e35
P356
10.1016/J.OPHTHA.2010.02.031
P577
2010-04-28T00:00:00Z